TERNS PHARMACEUTICALS INC (TERN)

US8808811074 - Common Stock

4.91  +0.27 (+5.82%)

After market: 4.86 -0.05 (-1.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.001.00M0.000.00
Minority Interest Expense
N/AN/A0.00520.00K210.00K
Operating Expenses
102.56M62.03M50.86M37.03M70.20M
Research and Development
63.50M39.62M31.31M28.03M61.53M
Selling, General, and Administrative Expenses
39.06M22.41M19.55M9.00M8.66M
Operating Income
-102.56M-62.03M-49.86M-37.03M-70.20M
Interest Income/Expense
12.90M2.11M170.00K60.00K1.20M
Other Income/Expense
-314.00K-70.00K40.00K-2.79M150.00K
Income Before Taxes
-89.97M-59.99M-49.65M-39.76M-68.84M
Income Tax
239.00K360.00K510.00K810.00K-20.00K
Net Income
-90.21M-60.35M-50.16M-29.35M-68.61M
EBITDA
-102.27M-61.55M-49.35M-36.64M-70.00M
 
Per Share Data
EPS Diluted Total Ops
-1.27-1.67-2.21-1.29-3.02
Non GAAP EPS
-1.27-1.83-2.34N/AN/A
 
Statistics
Profit Margin
N/AN/A-5016.00%N/AN/A
Operating Profit Margin
N/AN/A-4986.00%N/AN/A

All data in USD

Charts